Evidence map›Paper›PMID 38585372›Full record

ArticlePhysics and imaging in radiation oncology2024

[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program.

Nathaniel Barry, Eng-Siew Koh, Martin A Ebert, Alisha Moore, Roslyn J Francis, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Sweet P Ng, Michael Back, Benjamin Chua and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Nathaniel BarrySchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
Eng-Siew KohSouth Western Sydney Clinical School, University of New South Wales, Australia.
Martin A EbertSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
Alisha MooreTrans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
Roslyn J FrancisDepartment of Nuclear Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Pejman RowshanfarzadSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
Ghulam Mubashar HassanSchool of Physics, Mathematics and Computing, University of Western Australia, Crawley, WA, Australia.
Sweet P NgDepartment of Radiation Oncology, Austin Health, Heidelberg, VIC, Australia.
Michael BackDepartment of Radiation Oncology, Royal North Shore Hospital, Sydney, NSW, Australia.
Benjamin ChuaDepartment of Radiation Oncology, Royal Brisbane Womens Hospital, Brisbane, QLD, Australia.
Mark B PinkhamDepartment of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Andrew PullarDepartment of Radiation Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Claire PhillipsDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
Joseph SiaDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, VIC, Australia.
Peter GorayskiDepartment of Radiation Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Hien LeDepartment of Radiation Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Suki GillDepartment of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Jeremy CrokerDepartment of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Nicholas BucknellDepartment of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Catherine BettingtonDepartment of Radiation Oncology, Royal Brisbane Womens Hospital, Brisbane, QLD, Australia.
Farhan SyedDepartment of Radiation Oncology, The Canberra Hospital, Canberra, ACT, Australia.
Kylie JungDepartment of Radiation Oncology, The Canberra Hospital, Canberra, ACT, Australia.
Joe ChangSouth Western Sydney Clinical School, University of New South Wales, Australia.
Andrej BeceDepartment of Radiation Oncology, St George Hospital, Kogarah, NSW, Australia.
Catherine ClarkDepartment of Radiation Oncology, St George Hospital, Kogarah, NSW, Australia.
Mori WadaDepartment of Radiation Oncology, Austin Health, Heidelberg, VIC, Australia.
Olivia CookTrans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
Angela WhiteheadTrans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
Alana RossiTrans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
Andrew GroseTrans Tasman Radiation Oncology Group (TROG) Cancer Research, Newcastle, NSW Australia.
Andrew M ScottDepartment of Molecular Imaging and Therapy, Austin Health, and University of Melbourne, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing program aimed to assess the feasibility in Radiation Oncologist (RO) derivation of standard-of-care target volumes (TV Materials and methods: Central review and analysis of TV Results: Data from 19 ROs across 10 trial sites (54 initial submissions, 8 resubmissions requested, 4 conditional passes) was assessed with an initial pass rate of 77.8 %; all resubmissions passed. TV Conclusions: The credentialing program demonstrated feasibility in successful credentialing of 19 ROs across 10 sites, increasing national expertise in TV

Indexed as

Clinical trialsCredentialingFET PETGlioblastomaTreatment planning

Identifiers

PMID38585372
PMCPMC10998205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.